Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

mRNA vaccine in cancer therapy: Current advance and future outlook.

  • Authors : Li Y; Department of Breast Surgery, Baoji Municipal Central Hospital, Weibin District, Baoji, Shaanxi, China.; Wang M

Subjects: Cancer Vaccines*/Cancer Vaccines*/Cancer Vaccines*/genetics ; Cancer Vaccines*/Cancer Vaccines*/Cancer Vaccines*/therapeutic use ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: Clinical and translational medicine [Clin Transl Med] 2023 Aug; Vol. 13 (8), pp. e1384.Publisher: Wiley Country of Publication: United States NLM ID: 101597971 Publication Model: Print Cited Medium: Internet

تفاصيل العنوان

×
Academic Journal

Tumor vaccine based on extracellular vesicles derived from γδ-T cells exerts dual antitumor activities.

  • Authors : Wang X; Department of Paediatrics & Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.; Zhang Y

Subjects: Cancer Vaccines* ; Extracellular Vesicles*; Adjuvants, Immunologic

  • Source: Journal of extracellular vesicles [J Extracell Vesicles] 2023 Sep; Vol. 12 (9), pp. e12360.Publisher: Wiley Country of Publication: United States NLM ID: 101610479 Publication Model: Print Cited Medium: Internet

تفاصيل العنوان

×
Academic Journal

Biosynthetic neoantigen displayed on bacteria derived vesicles elicit systemic antitumour immunity.

  • Authors : Meng F; Department of Pharmacology, Molecular Cancer Research Center, School of Medicine, Shenzhen Campus of Sun Yat-sen University, Sun Yat-sen University, Shenzhen, Guangdong, PR China.; Li L

Subjects: Cancer Vaccines*/Cancer Vaccines*/Cancer Vaccines*/therapeutic use ; Neoplasms*/Neoplasms*/Neoplasms*/therapy; Humans

  • Source: Journal of extracellular vesicles [J Extracell Vesicles] 2022 Dec; Vol. 11 (12), pp. e12289.Publisher: Wiley Country of Publication: United States NLM ID: 101610479 Publication Model: Print Cited Medium: Internet

تفاصيل العنوان

×
Academic Journal

Neoantigen-based cancer vaccination using chimeric RNA-loaded dendritic cell-derived extracellular vesicles.

  • Authors : Xiong X; Institute of Precision Cancer Medicine and Pathology, and Department of Pathology, School of Medicine, and Department of General Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, Guangdong, China.; Ke X

Subjects: Cancer Vaccines* ; Extracellular Vesicles* ; Neoplasms*/Neoplasms*/Neoplasms*/therapy

  • Source: Journal of extracellular vesicles [J Extracell Vesicles] 2022 Aug; Vol. 11 (8), pp. e12243.Publisher: Wiley Country of Publication: United States NLM ID: 101610479 Publication Model: Print Cited Medium: Internet

تفاصيل العنوان

×
Academic Journal

The Development of Vaccines from Synthetic Tumor-Associated Mucin Glycopeptides and their Glycosylation-Dependent Immune Response.

  • Authors : Stergiou N; Radionuclide Center, Radiology and Nuclear medicine Amsterdam UMC, VU University, De Boelelaan 1085c, 1081 HV, Amsterdam, the Netherlands.; Urschbach M

Subjects: Cancer Vaccines*/Cancer Vaccines*/Cancer Vaccines*/immunology ; Glycopeptides*; Mucins/Mucins/Mucins/*immunology

  • Source: Chemical record (New York, N.Y.) [Chem Rec] 2021 Nov; Vol. 21 (11), pp. 3313-3331. Date of Electronic Publication: 2021 Nov 23.Publisher: Wiley Country of Publication: United States NLM ID: 101085550 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

×
Academic Journal

IDENTIFICATION OF MHC PEPTIDES USING MASS SPECTROMETRY FOR NEOANTIGEN DISCOVERY AND CANCER VACCINE DEVELOPMENT.

  • Authors : Chen R; Human Health Therapeutics Research Centre, National Research Council Canada, 100 Sussex Drive, Ottawa, Ontario, K1A 0R6, Canada.; Fulton KM

Subjects: Major Histocompatibility Complex*; Cancer Vaccines/Cancer Vaccines/Cancer Vaccines/*chemistry ; Neoplasms/Neoplasms/Neoplasms/*prevention & control

  • Source: Mass spectrometry reviews [Mass Spectrom Rev] 2021 Mar; Vol. 40 (2), pp. 110-125. Date of Electronic Publication: 2019 Dec 25.Publisher: Wiley Country of Publication: United States NLM ID: 8219702 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

×
Academic Journal

Telomerase and its potential for therapeutic intervention.

  • Authors : Phatak P; Department of Pharmacology and Experimental Therapeutics, and Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD 21201, USA.; Burger AM

Subjects: Cancer Vaccines*/Cancer Vaccines*/Cancer Vaccines*/chemistry ; Cancer Vaccines*/Cancer Vaccines*/Cancer Vaccines*/pharmacology ; Cancer Vaccines*/Cancer Vaccines*/Cancer Vaccines*/therapeutic use

  • Source: British journal of pharmacology [Br J Pharmacol] 2007 Dec; Vol. 152 (7), pp. 1003-11. Date of Electronic Publication: 2007 Jul 02.Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print-Electronic Cited Medium: Print

تفاصيل العنوان

×
Academic Journal

Objective clinical regression of metastatic breast cancer in disparate sites after use of whole-cell vaccine genetically modified to release sargramostim.

  • Authors : Wiseman CL; Immunotherapy Laboratory, St Vincent Medical Center, Los Angeles, CA 90057, USA. ; Kharazi A

Subjects: Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*therapy ; Cancer Vaccines/Cancer Vaccines/Cancer Vaccines/*genetics ; Cancer Vaccines/Cancer Vaccines/Cancer Vaccines/*therapeutic use

  • Source: The breast journal [Breast J] 2006 Sep-Oct; Vol. 12 (5), pp. 475-80.Publisher: Wiley Country of Publication: United States NLM ID: 9505539 Publication Model: Print Cited Medium: Print

تفاصيل العنوان

×
  • 1-10 of  366 نتائج ل ""Cancer Vaccines""